Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pioglitazone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pioglitazone 30mg tablets
0601023B0AAABAB
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | 64,569 |
|
Pioglitazone 45mg tablets
0601023B0AAACAC
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | 50,341 |
|
Pioglitazone 15mg tablets
0601023B0AAAAAA
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | 46,336 |
|
Actos 30mg tablets
0601023B0BBABAB
|
Actos | Pioglitazone hydrochloride | Endocrine System | 50 |
|
Actos 15mg tablets
0601023B0BBAAAA
|
Actos | Pioglitazone hydrochloride | Endocrine System | 45 |
|
Actos 45mg tablets
0601023B0BBACAC
|
Actos | Pioglitazone hydrochloride | Endocrine System | 45 |
|
Diabiom 15mg tablets
0601023B0BEAAAA
|
Diabiom | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Diabiom 30mg tablets
0601023B0BEABAB
|
Diabiom | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Diabiom 45mg tablets
0601023B0BEACAC
|
Diabiom | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 15mg tablets
0601023B0BDACAA
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 30mg tablets
0601023B0BDAAAB
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 45mg tablets
0601023B0BDABAC
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 15mg tablets (Arrow)
0601023B0BCADAA
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 15mg tablets (Teva)
0601023B0BCAAAA
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 30mg tablets (Arrow)
0601023B0BCAEAB
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 30mg tablets (Teva)
0601023B0BCABAB
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 45mg tablets (Arrow)
0601023B0BCAFAC
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 45mg tablets (Teva)
0601023B0BCACAC
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 15mg/5ml oral suspension
0601023B0AAAEAE
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 30mg/5ml oral suspension
0601023B0AAADAD
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 45mg/5ml oral suspension
0601023B0AAAFAF
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.